PMID- 27732109 OWN - NLM STAT- MEDLINE DCOM- 20171204 LR - 20180430 IS - 1460-2202 (Electronic) IS - 0271-3683 (Linking) VI - 42 IP - 5 DP - 2017 May TI - Ischemia Reperfusion Injury Triggers TNFalpha Induced-Necroptosis in Rat Retina. PG - 771-779 LID - 10.1080/02713683.2016.1227449 [doi] AB - PURPOSE: A recent study revealed a novel form of cell death, termed necroptosis, or programmed necrosis. Previous research indicated that after ischemia-reperfusion (IR) injury to the retina, Tumor Necrosis Factor alpha (TNFalpha) is increased, which may activate necroptosis. This study observed macroglial cell activation, and in particular, astrocyte activation, after the release of TNFalpha and other necroptosis factors in the rat retina due to IR. MATERIALS AND METHODS: IR was induced in the retinas of adult male Sprague-Dawley rats by increasing the intraocular pressure to 160 mmHg and then allowing reperfusion. In addition, to inhibit necroptosis, Nec-1 (necrostatin-1) was injected intravitreally after IR. Rats were sacrificed after reperfusion at 12 hours, 1, 3, and 5 days, and 1 and 2 weeks. Retinas from each time point were analyzed by immunohistochemistry (IHC) and Western blotting (WB) to identify the initiator of necroptosis, TNFalpha, the expression of necroptosis factors, such as receptor interacting protein (RIP) 1, 3, and inactive caspase 8, and Brn3a. RESULTS: Cell death in the IR-injured retinas was identified by cell counting. We found decreased retinal cell numbers in the inner and outer nuclear layers (INL and ONL), as well as in the ganglion cell layer (GCL). Increased glial cell activation was detected by using glial fibrillary acidic protein (GFAP) IHC. TNFalpha, RIP1, RIP3, and inactive caspase 8 were mainly expressed in the GCL after IR, as determined by IHC and WB. Nec-1 inhibited RIP1, a necroptosis factor, indicating protection against retinal cell loss after IR injury. CONCLUSIONS: We showed that IR injury triggered increases in both activation of astrocytes and the expression of TNFalpha. In addition, TNFalpha, which was activated by IR, triggered the release of necroptosis factors, particularly, in GCL. Inhibition of necroptosis using Nec-1 decreased the level of RIP1 and retinal cell loss in IR-injured retinas. FAU - Kim, Cho Rong AU - Kim CR AD - a Department of Ophthalmology and Visual Science , Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea , Seoul , Korea. FAU - Kim, Jie Hyun AU - Kim JH AD - a Department of Ophthalmology and Visual Science , Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea , Seoul , Korea. FAU - Park, Hae-Young Lopilly AU - Park HL AD - a Department of Ophthalmology and Visual Science , Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea , Seoul , Korea. FAU - Park, Chan Kee AU - Park CK AD - a Department of Ophthalmology and Visual Science , Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea , Seoul , Korea. LA - eng PT - Journal Article DEP - 20161012 PL - England TA - Curr Eye Res JT - Current eye research JID - 8104312 RN - 0 (Imidazoles) RN - 0 (Indoles) RN - 0 (Tumor Necrosis Factor-alpha) RN - 0 (necrostatin-1) SB - IM MH - Animals MH - *Apoptosis MH - Blotting, Western MH - Disease Models, Animal MH - Imidazoles/*pharmacology MH - Immunohistochemistry MH - Indoles/*pharmacology MH - Male MH - Necrosis MH - Rats MH - Rats, Sprague-Dawley MH - Reperfusion Injury/*complications/diagnosis/metabolism MH - Retina/drug effects/*pathology MH - Retinal Diseases/diagnosis/*etiology/metabolism MH - Tumor Necrosis Factor-alpha/toxicity OTO - NOTNLM OT - Ganglion cell layer OT - TNFalpha OT - ischemia-reperfusion OT - necroptosis OT - necrostatin-1 EDAT- 2016/10/13 06:00 MHDA- 2017/12/05 06:00 CRDT- 2016/10/13 06:00 PHST- 2016/10/13 06:00 [pubmed] PHST- 2017/12/05 06:00 [medline] PHST- 2016/10/13 06:00 [entrez] AID - 10.1080/02713683.2016.1227449 [doi] PST - ppublish SO - Curr Eye Res. 2017 May;42(5):771-779. doi: 10.1080/02713683.2016.1227449. Epub 2016 Oct 12.